Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
BiondVax Pharmaceuticals Ltd. Stock Forecast NASDAQ:BVXV
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-01-26 | 430.3% | Aegis Capital | $7.00 | Initiates Coverage On | Buy |
BVXV Stock Trend
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.21 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.
Given the current short-term trend, the stock is expected to rise 11.21% during the next 3 months and, with a 90% probability hold a price between $1.34 and $2.19 at the end of this 3-month period.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-18 | $1.21 | $1.59 | $1.98 |
| 2022-05-19 | $1.21 | $1.60 | $1.98 |
| 2022-05-20 | $1.22 | $1.60 | $1.98 |
| 2022-05-23 | $1.22 | $1.60 | $1.99 |
| 2022-05-24 | $1.22 | $1.61 | $1.99 |
| 2022-05-25 | $1.23 | $1.61 | $1.99 |
| 2022-05-26 | $1.23 | $1.61 | $2.00 |
| 2022-05-27 | $1.23 | $1.62 | $2.00 |
| 2022-05-31 | $1.24 | $1.62 | $2.00 |
| 2022-06-01 | $1.24 | $1.62 | $2.01 |
| 2022-06-02 | $1.24 | $1.63 | $2.01 |
| 2022-06-03 | $1.25 | $1.63 | $2.01 |
| 2022-06-06 | $1.25 | $1.63 | $2.02 |
| 2022-06-07 | $1.25 | $1.64 | $2.02 |
| 2022-06-08 | $1.26 | $1.64 | $2.02 |
| 2022-06-09 | $1.26 | $1.64 | $2.03 |
| 2022-06-10 | $1.26 | $1.65 | $2.03 |
| 2022-06-13 | $1.27 | $1.65 | $2.03 |
| 2022-06-14 | $1.27 | $1.65 | $2.04 |
| 2022-06-15 | $1.27 | $1.66 | $2.04 |
| 2022-06-16 | $1.28 | $1.66 | $2.04 |
| 2022-06-17 | $1.28 | $1.66 | $2.05 |
| 2022-06-21 | $1.28 | $1.67 | $2.05 |
| 2022-06-22 | $1.29 | $1.67 | $2.05 |
| 2022-06-23 | $1.29 | $1.67 | $2.06 |
| 2022-06-24 | $1.29 | $1.68 | $2.06 |
| 2022-06-27 | $1.30 | $1.68 | $2.06 |
| 2022-06-28 | $1.30 | $1.68 | $2.07 |
| 2022-06-29 | $1.30 | $1.69 | $2.07 |
| 2022-06-30 | $1.31 | $1.69 | $2.07 |
Biondvax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. The company offers M-001, a synthetic peptide-based protein, which is in Phase 2 clinical development stage targeting seasonal and pandemic strains of the influenza virus. Biondvax Pharmaceuticals Ltd. was founded in 2003 and is based in Ness Ziona, Israel.... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 108 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
